We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Market for Women’s Health Devices Sees Moderate Growth

By HospiMedica International staff writers
Posted on 29 Nov 2015
Print article
The global market for women’s health devices is forecast to grow from an estimated USD 1.8 billion in 2014 to approximately USD 2.4 billion in 2021, representing a compound annual growth rate of 3.7%. These are the latest findings of GlobalData (London, United Kingdom), an international business intelligence provider.

The market encompasses treatments for conditions that are particular to the adult female anatomy; this includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, pelvic disorders such as female stress urinary incontinence, and anti-conceptive procedures. Minimally invasive technologies to treat these conditions as alternatives to conventional surgery are expected to see increased adoption in the coming years, due to increased physician and patient awareness and an increasing number of women proactively seeking treatment.

Technologies include endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. As more women seek treatment for uterine health and incontinence issues, the market will become increasingly competitive, provided that the new technology meets efficacy and safety standards. However, recent lawsuits related to safety issues with some of these devices have received widespread media attention, particularly in the urinary incontinence sling market, causing some skepticism.

“The understanding that a woman’s quality of life can be vastly improved by new technologies coincides with the awareness that a variety of new treatment options, such as global endometrial ablation and uterine artery embolization, are far less invasive than surgery,” said GlobalData analyst Premdharan Meyyan. “For women who suffer from abnormal uterine conditions, such as heavy menstrual bleeding and uterine fibroids, these new technologies offer safe and effective alternative treatment options to patients who do not wish to undergo invasive surgery.”

Related Links:

GlobalData


Gold Member
12-Channel ECG
CM1200B
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Critical Care

view channel
Image: The largest scale analysis compared longer-term percutaneous devices for aortic valve replacement versus surgery (Photo courtesy of Adobe Stock)

Transcatheter Valve Replacement Outcomes Similar To Surgery, Finds Study

A new study has shown that a minimally invasive procedure for replacing the aortic valve in the heart—known as transcatheter aortic valve replacement (TAVR)—is on par with the more traditional surgical... Read more

Surgical Techniques

view channel
Image: The AR tech allows for sub-millimeter accuracy, helping to potentially reduce risks (Photo courtesy of Medivis)

AR Surgical Technology Translates Complex 2D Medical Imaging to Enhance Accuracy

Surgeons often have to switch their focus between a patient’s data displayed on a screen or clipboard and the patient themselves during procedures. But that is about to change. Surgeons can now utilize... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more